The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia

1. Rojo-Bustamante, E.
2. Abellanas, M.A.
3. Clavero, P.
4. Thiolat, M.-L.
5. Li, Q.
6. Luquin, M.R.
7. Bezard, E.
8. Aymerich, M.S.